Elinx Stock

Elinx Equity

The The Equity of Elinx (ELNX) as of Aug 15, 2026 is -3.55 M USD.

Equity

-3.55 MUSD

Last updated:

In 2026, Elinx's equity was -3.55 M USD, a % increase from the - USD equity in the previous year.

Access this data via the Eulerpool API

Elinx Stock analysis

What does Elinx do? Aperture Health Inc. is a globally operating company in the healthcare industry based in San Francisco, California. The company was founded in 2014 by a group of healthcare experts with the goal of revolutionizing healthcare. Since its inception, the company has experienced rapid growth and is now a major player in the healthcare market. Aperture Health Inc.'s business model is based on the development and sale of innovative products and services in the healthcare sector. The company operates in multiple business fields, all aiming to improve healthcare. This includes digital health, clinical diagnostic tests, healthcare, and health insurance. In the field of digital health, the company offers a wide range of solutions aimed at simplifying healthcare management. These solutions include mobile health applications that allow users to monitor and track their health data. The company is also working on the development of personalized medical devices and wearables that help diagnose and treat various health issues. Aperture Health Inc. is also involved in the development and manufacturing of clinical diagnostic tests. The company has developed a wide range of diagnostic tests for diseases such as cancer, diabetes, and HIV. These tests are fast and easy to perform and provide accurate results. In the area of healthcare, the company provides a wide range of services aimed at improving the quality of healthcare. These services include access to specialized medical professionals, assistance in organizing doctor visits, and prescription of medications. Aperture Health Inc. works closely with hospitals and medical facilities to provide seamless and high-quality healthcare. Aperture Health Inc. also offers innovative health insurance tailored to the needs of customers. These insurances combine a wide range of health insurance options that meet the customers' needs with an intelligent health management system that allows policyholders to monitor and improve their health. The company is also engaged in research and development of new treatment methods. Aperture Health Inc. collaborates closely with medical research institutions and professionals to develop new and innovative treatment methods that aim to improve healthcare globally. In summary, Aperture Health Inc. is a company that aims to revolutionize healthcare worldwide. The company offers innovative products and services aimed at improving people's health and increasing their quality of life. With a wide range of solutions in various business fields, Aperture Health Inc. has become a major player in the healthcare industry and will continue to play an important role in the future. Elinx is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Elinx's Equity

Elinx's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Elinx's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Elinx's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Elinx's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Elinx’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Elinx stock

The Equity of Elinx is -3.55 M USD in 2026.

On Eulerpool you can find the complete historical development of The Equity Elinx since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Elinx historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Elinx

All Key Metrics — Elinx